Lilly Highlighting Once-Daily Cymbalta Dose
This article was originally published in The Pink Sheet Daily
Executive Summary
Lilly will focus on the 60 mg once a day dose of Cymbalta in detailing the antidepressant to prescribers
You may also be interested in...
Cymbalta Approved; Lilly Antidepressant Will Be Available By Late August
Cymbalta (duloxetine) clears FDA for major depressive disorder after a lengthy review. It will be priced comparably to other antidepressants, including Wyeth's Effexor XR (venlafaxine), the other marketed selective serotonin/norepinephrine reuptake inhibitor.
Cymbalta Approved; Lilly Antidepressant Will Be Available By Late August
Cymbalta (duloxetine) clears FDA for major depressive disorder after a lengthy review. It will be priced comparably to other antidepressants, including Wyeth's Effexor XR (venlafaxine), the other marketed selective serotonin/norepinephrine reuptake inhibitor.
Cymbalta Once-Daily Dosing Not Vital To Product's Success, Lilly Suggests
Lilly says it has data on twice-daily Cymbalta dosing, and analysts express concern that the company has not previously discussed the possibility of b.i.d. administration in labeling. Exec VP-Science & Technology Paul maintains Cymbalta is also "very effective and very safe" taken once a day.